Cefepime and death: Reality to the rescue

Clinical Infectious Diseases

Volumn 51, Issue 4, 2010, Pages 390-391

  Freifeld, Alison G ^a   Sepkowitz, Kent ^b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFEPIME; ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE;

ANTIBIOTIC THERAPY; BACTEREMIA; CLINICAL TRIAL; DRUG FATALITY; DRUG SAFETY; FEBRILE NEUTROPENIA; FOOD AND DRUG ADMINISTRATION; HUMAN; NOTE; PNEUMONIA; PRESCRIPTION; PRIORITY JOURNAL; PUBLICATION; RISK BENEFIT ANALYSIS; BACTERIAL INFECTIONS; MORTALITY;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CEPHALOSPORINS; HUMANS;

EID: 77955678559     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/655132     Document Type: Note

References (2)

1. Yahav D, Paul M, Fraser A, Sarid N, Leibovici L. Efficacy and safety of cefepime: a systematic review and meta-analysis. Lancet Infect Dis 2007; 7:338-348.
2. KimPW,Wu Y-t, Cooper C, et al. Meta-analysis of a possible signal of increased mortality associated with cefepime use. Clin Infect Dis 2010; 51(4):381-389 (in this issue).